Epigenetics and epilepsy

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 12, 2015, Pages

  Henshall, David C ^a   Kobow, Katja ^b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HISTONE; HISTONE H4; LIM KINASE; LONG UNTRANSLATED RNA; METHYL CPG BINDING PROTEIN; MICRORNA; REELIN; UNTRANSLATED RNA;

ACETYLATION; ARTICLE; DNA METHYLATION; EPIGENETICS; EPILEPSY; EPILEPTOGENESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; NONHUMAN; SEIZURE THRESHOLD; ANIMAL; BRAIN; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; PROTEIN PROCESSING; RAT;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; EPILEPSY; HISTONES; HUMANS; MICE; MICRORNAS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RNA, LONG NONCODING;

EID: 84949238792     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a022731     Document Type: Article

References (117)

1. Akbarian S, Chen RZ, Gribnau J, Rasmussen TP, Fong H, Jaenisch R, Jones EG. 2001. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis 8: 784-791.
2. Allis CD, Jenuwein T, Reinberg D. 2008. Epigenetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.
4. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM. 2009. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotech 27: 361-368.
5. Barres R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR. 2009. Non-CpG methylation of the PGC-1a promoter through DNMT3B controls mitochondrial density. Cell Metab 10: 189-198.
6. Bassuk AG, Wallace RH, Buhr A, Buller AR, Afawi Z, Shimojo M, Miyata S, Chen S, Gonzalez-Alegre P, Griesbach HL, et al. 2008. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Gen 83: 572-581.
7. Becker PB, Horz W. 2002. ATP-dependent nucleosome remodeling. Ann Rev Biochem 71: 247-273.
8. Belhedi N, Perroud N, Karege F, Vessaz M, Malafosse A, Salzmann A. 2014. Increased CPA6 promoter methylation in focal epilepsy and in febrile seizures. Epilepsy Res 108: 144-148.
9. Benhamed M, Herbig U, Ye T, Dejean A, Bischof O. 2012. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nat Cell Biol 14: 266-275.
10. Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan Z, Zhang MQ, Sedel F, Jourdren L, Coulpier F, et al. 2010. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J 29: 3082-3093.
11. Bhadra T, Bhattacharyya M, Feuerbach L, Lengauer T, Bandyopadhyay S. 2013. DNA methylation patterns facilitate the identification of microRNA transcription start sites: A brain-specific study. PLoS ONE 8: e66722.
12. Bhutani N, Burns DM, Blau HM. 2011. DNA demethylation dynamics. Cell 146: 866-872.
13. Bodda C, Tantra M, Mollajew R, Arunachalam JP, Laccone FA, Can K, Rosenberger A, Mironov SL, Ehrenreich H, Mannan AU. 2013. Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. Am J Path 183: 195-210.
14. Chouliaras L, Mastroeni D, Delvaux E, Grover A, Kenis G, Hof PR, Steinbusch HW, Coleman PD, Rutten BP, van den Hove DL. 2013. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients. Neurobiol Aging 34: 2091-2099.
15. Clark SJ, Harrison J, Frommer M. 1995. CpNpG methylation in mammalian cells. Nat Genet 10: 20-27.
16. Crosio C, Heitz E, Allis CD, Borrelli E, Sassone-Corsi P. 2003. Chromatin remodeling and neuronal response: Multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J Cell Sci 116: 4905-4914.
17. Crowe SL, Tsukerman S, Gale K, Jorgensen TJ, Kondratyev AD. 2011. Phosphorylation of histone H2A.X as an early marker of neuronal endangerment following seizures in the adult rat brain. J Neurosci 31: 7648-7656.
18. Dulac C. 2010. Brain function and chromatin plasticity. Nature 465: 728-735.
19. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, et al. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci 104: 15805-15810.
20. Fan G, Beard C, Chen RZ, Csankovszki G, Sun Y, Siniaia M, Biniszkiewicz D, Bates B, Lee PP, Kuhn R, et al. 2001. DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J Neurosci 21: 788-797.
21. Feinberg AP. 2007. Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433-440.
22. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, Silva AJ, Fan G. 2010. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13: 423-430.
23. Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L, Mak G, Kim D, Su SC, Tsai LH. 2010. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466: 1105-1109.
24. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, et al. 2001. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20: 6969-78.
25. Graff J, Kim D, Dobbin MM, Tsai LH. 2011. Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol Rev 91: 603-649.
26. Graff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M, et al. 2012. An epigenetic blockade of cognitive functions in the neurode-generating brain. Nature 483: 222-226.
27. Grandjean V, Yaman R, Cuzin F, Rassoulzadegan M. 2007. Inheritance of an epigenetic mark: The CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation. PLoS ONE 2: e1136.
28. Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, Costa E. 2005. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci 102: 9341-9346.
29. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, et al. 2011. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 14: 1345-1351.
30. Hahn MA, Qiu R, Wu X, Li AX, Zhang H, Wang J, Jui J, Jin SG, Jiang Y, Pfeifer GP, et al. 2013. Dynamics of 5-hydrox-ymethylcytosine and chromatin marks in mammalian neurogenesis. Cell Rep 3: 291-300.
31. Hauke J, Riessland M, Lunke S, Eyupoglu IY, BlumCke I, El-Osta A, Wirth B, Hahnen E. 2009. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be by-passed by histone deacetylase inhibition. Hum Mol Genet 18: 304-317.
32. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. 2005. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003.
33. Henshall DC. 2013a. Antagomirs and microRNA in status epilepticus. Epilepsia 54: 17-19.
34. Henshall DC. 2013b. MicroRNAs in the pathophysiology and treatment of status epilepticus. Front Mol Neurosci 6: 11.
35. Henshall DC. 2014. MicroRNA and epilepsy: Profiling, functions and potential clinical applications. Curr Opin Neurol 27: 199-205.
36. Hoffmann K, Czapp M, Loscher W. 2008. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: Role of inhibition of histone deacetylases? Epilepsy Res 81: 107-113.
37. Hu K, Zhang C, Long L, Long X, Feng L, Li Y, Xiao B. 2011a. Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett 488: 252-257.
38. Hu XL, Cheng X, Cai L, Tan GH, Xu L, Feng XY, Lu TJ, Xiong H, Fei J, Xiong ZQ. 2011b. Conditional deletion of NRSF in forebrain neurons accelerates epileptogenesis in the kindling model. Cereb Cortex 21: 2158-2165.
39. Hu K, Xie YY, Zhang C, Ouyang DS, Long HY, Sun DN, Long LL, Feng L, Li Y, Xiao B. 2012. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci 13: 115.
40. Huang Y, Myers SJ, Dingledine R. 1999. Transcriptional repression by REST: Recruitment of Sin3A and histone deacetylase to neuronal genes. Nat Neurosci 2: 867-872.
41. Huang Y, Doherty JJ, Dingledine R. 2002. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J Neurosci 22: 8422-8428.
42. Huang Y, Zhao F, Wang L, Yin H, Zhou C, Wang X. 2012. Increased expression of histone deacetylases 2 in temporal lobe epilepsy: A study of epileptic patients and rat models. Synapse 66: 151-159.
43. Hwang JY, Aromolaran KA, Zukin RS. 2013. Epigenetic mechanisms in stroke and epilepsy. Neuropsychopharmacology 38: 167-182.
44. Ichiyanagi T, Ichiyanagi K, Miyake M, Sasaki H. 2013. Ac- cumulation and loss of asymmetric non-CpG methylation during male germ-cell development. Nucleic Acids Res 41: 738-745.
45. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 33: 245-254.
46. Jakovcevski M, Akbarian S. 2012. Epigenetic mechanisms in neurological disease. Nat Med 18: 1194-1204.
47. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80: 1611-1617.
48. Jessberger S, Nakashima K, Clemenson GD Jr, Mejia E, Mathews E, Ure K, Ogawa S, Sinton CM, Gage FH, Hsieh J. 2007. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J Neurosci 27: 5967-5975.
49. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, Engel T, McKiernan RC, Mouri G, Tanaka K, Sano T, Saugstad JA, Simon RP, et al. 2011. miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol 179: 2519-2532.
50. Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G, Sano T, O’Tuathaigh C, Waddington JL, Prenter S, et al. 2012. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18: 1087-1094.
51. Jimenez-Mateos EM, Engel T, Merino-Serrais P, Fernaud-Espinosa I, Rodriguez-Alvarez N, Reynolds J, Reschke CR, Conroy RM, McKiernan RC, deFelipe J, et al. 2014. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus. Brain Struct Func doi: 10.1007/s00429-014-0798-5.
52. Kan AA, van Erp S, Derijck AA, de Wit M, Hessel EV, O’Duibhir E, de Jager W, Van Rijen PC, Gosselaar PH, de Graan PN, et al. 2012. Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell Mol Life Sci 69: 3127-3145.
53. Kim DH, Saetrom P, Snove O Jr, Rossi JJ. 2008. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci 105: 16230-16235.
54. Kobow K, BlumCke I. 2012. The emerging role of DNA methylation in epileptogenesis. Epilepsia 53: 11-20.
55. Kobow K, Jeske I, Hildebrandt M, Hauke J, Hahnen E, Buslei R, Buchfelder M, Weigel D, Stefan H, Kasper B, et al. 2009. Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol 68: 356-364.
56. Kobow K, Kaspi A, Harikrishnan KN, Kiese K, Ziemann M, Khurana I, Fritzsche I, Hauke J, Hahnen E, Coras R, et al. 2013. Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropath 126: 741-756.
57. Kurita M, Holloway T, Garcia-Bea A, Kozlenkov A, Friedman AK, Moreno JL, Heshmati M, Golden SA, Kennedy PJ, Takahashi N, et al. 2012. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci 15: 1245-1254.
58. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, Low HM, Kin Sung KW, Rigoutsos I, Loring J, et al. 2010. Dynamic changes in the human methylome during differentiation. Genome Res 20: 320-331.
59. Levenson JM, Roth TL, Lubin FD, Miller CA, Huang IC, Desai P, Malone LM, Sweatt JD. 2006. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281: 15763-15773.
60. Li E, Bestor TH, Jaenisch R. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
61. Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, Lucero J, Huang Y, Dwork AJ, Schultz MD, et al. 2013. Global epigenomic reconfiguration during mammalian brain development. Science 341: 1237905.
62. Liu M, Sheng Z, Cai L, Zhao K, Tian Y, Fei J. 2012. Neuronal conditional knockout of NRSF decreases vulnerability to seizures induced by pentylenetetrazol in mice. Acta Biochim Biophysica Sin 44: 476-482.
63. Lubin FD. 2012. Epileptogenesis: Can the science of epigenetics give us answers? Epilepsy Curr 12: 105-110.
64. Machnes ZM, Huang TC, Chang PK, Gill R, Reist N, Dezsi G, Ozturk E, Charron F, O’Brien TJ, Jones NC, et al. 2013. DNA methylation mediates persistent epileptiform activity in vitro and in vivo. PLoS ONE 8: e76299.
65. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE. 2003. DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation. Science 302: 890-893.
66. Maxwell SS, Pelka GJ, Tam PP, El-Osta A. 2013. Chromatin context and ncRNA highlight targets of MeCP2 in brain. RNA Biol 10: 1741-1757.
67. McClelland S, Flynn C, Dube C, Richichi C, Zha Q, Ghestem A, Esclapez M, Bernard C, Baram TZ. 2011. Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic nucleotide gated channelopathy in experimental temporal lobe epilepsy. Ann Neurol 70: 454-464.
68. McKiernan RC, Jimenez-Mateos EM, Bray I, Engel T, Brennan GP, Sano T, Michalak Z, Moran C, Delanty N, Farrell M, et al. 2012a. Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS ONE 7: e35921.
69. McKiernan RC, Jimenez-Mateos EM, Sano T, Bray I, Stallings RL, Simon RP, Henshall DC. 2012b. Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death. Exp Neurol 237: 346-354.
70. Mellen M, Ayata P, Dewell S, Kriaucionis S, Heintz N. 2012. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151: 1417-1430.
71. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. 2008. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci 105: 716-721.
72. Miller-Delaney SF, Das S, Sano T, Jimenez-Mateos EM, Bryan K, Buckley PG, Stallings RL, Henshall DC. 2012. Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J Neurosci 32: 1577-1588.
73. Modarresi F, Faghihi MA, Lopez-Toledano MA, Fatemi RP, Magistri M, Brothers SP, van der Brug MP, Wahlestedt C. 2012. Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotech 30: 453-459.
74. Nelson ED, Kavalali ET, Monteggia LM. 2008. Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 28: 395-406.
75. Ng SY, Lin L, Soh BS, Stanton LW. 2013. Long noncoding RNAs in development and disease of the central nervous system. Trend Genet 29: 461-468.
76. Nudelman AS, DiRocco DP, Lambert TJ, Garelick MG, Le J, Nathanson NM, Storm DR. 2010. Neuronal activity rapidly induces transcription of the CREB-regulated micro- RNA-132, in vivo. Hippocampus 20: 492-498.
77. Okano M, Bell DW, Haber DA, Li E. 1999. DNA methyl-transferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
78. Park HG, Yu HS, Park S, Ahn YM, Kim YS, Kim SH. 2014. Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex. Int J Neuropsychopharm 17: 14.
79. Peng J, Omran A, Ashhab MU, Kong H, Gan N, He F, Yin F. 2013. Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy. J Mol Neurosci 50: 291-297.
80. Pichardo-Casas I, Goff LA, Swerdel MR, Athie A, Davila J, Ramos-Brossier M, Lapid-Volosin M, Friedman WJ, Hart RP, Vaca L. 2012. Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation. Brain Res 1436: 20-33.
81. Pitkanen A, Lukasiuk K. 2011. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10: 173-186.
82. Qureshi IA, Mehler MF. 2012. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci 13: 528-541.
83. Qureshi IA, Mehler MF. 2013. Understanding neurological disease mechanisms in the era of epigenetics. JAMA Neurol 70: 703-710.
84. Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian development. Science 293: 1089-1093.
85. Risbud RM, Porter BE. 2013. Changes in microRNA expression in the whole hippocampus and hippocampal synap-toneurosome fraction following pilocarpine-induced sta- tus epilepticus. PLoS ONE 8: e53464.
86. Roopra A, Dingledine R, Hsieh J. 2012. Epigenetics and epilepsy. Epilepsia 53: 2-10.
87. Rossetti F, de Araujo Furtado M, Pak T, Bailey K, Shields M, Chanda S, Addis M, Robertson BD, Moffett M, Lumley LA, et al. 2012. Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure. Neurotoxicology 33: 500-511.
88. Rudenko A, Dawlaty Meelad M, Seo J, Cheng Albert W, Meng J, Le T, Faull Kym F, Jaenisch R, Tsai L-H. 2013. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 79: 1109-1122.
89. Ryley Parrish R, Albertson AJ, Buckingham SC, Hablitz JJ, Mascia KL, Davis Haselden W, Lubin FD. 2013. Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus. Neuroscience 248C: 602-619.
90. Sano T, Reynolds JP, Jimenez-Mateos EM, Matsushima S, Taki W, Henshall DC. 2012. MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis 3: e287.
91. Sapio MR, Salzmann A, Vessaz M, Crespel A, Lyons PJ, Malafosse A, Fricker LD. 2012. Naturally occurring carboxypeptidase A6 mutations: Effect on enzyme function and association with epilepsy. J Biol Chem 287: 42900-42909.
92. Scarpa S, Fuso A, D’Anselmi F, Cavallaro RA. 2003. Presenilin 1 gene silencing by S-adenosylmethionine: A treatment for Alzheimer disease? FEBS Lett 541: 145-148.
93. Schaukowitch K, Kim TK. 2014. Emerging epigenetic mechanisms of long non-coding RNAs. Neuroscience 264C: 25-38.
94. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME. 2006. A brain-specific micro-RNA regulates dendritic spine development. Nature 439: 283-289.
95. Sharma A. 2012. Genome-wide expression analysis in epilepsy: A synthetic review. Curr Top Med Chem 12: 1008-1032.
96. Sng JC, Taniura H, Yoneda Y. 2005. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. Neurosci Lett 386: 150-155.
97. Sng JC, Taniura H, Yoneda Y. 2006. Histone modifications in kainate-induced status epilepticus. Eur J Neurosci 23: 1269-1282.
98. Sweatt JD. 2013. The emerging field of neuroepigenetics. Neuron 80: 624-632.
99. Sweatt JD, Meany MJ, Nestler EJ, Akbarian S. 2013. Epigenetic regulation in the nervous system. Academic, San Diego.
100. Szulwach KE, Li X, Li Y, Song CX, Wu H, Dai Q, Irier H, Upadhyay AK, Gearing M, Levey AI, et al. 2011. 5-hmC-mediated epigenetic dynamics during postnatal neuro development and aging. Nat Neurosci 14: 1607-1616.
101. Tan CL, Plotkin JL, Veno MT, von Schimmelmann M, Feinberg P, Mann S, Handler A, Kjems J, Surmeier DJ, O’Carroll D, et al. 2013. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342: 1254-1258.
102. Taniura H, Sng JC, Yoneda Y. 2006. Histone modifications in status epilepticus induced by kainate. Histol Histopath 21: 785-791.
103. Tsankova NM, Kumar A, Nestler EJ. 2004. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24: 5603-5610.
104. Urdinguio RG, Sanchez-Mut JV, Esteller M. 2009. Epigenetic mechanisms in neurological diseases: Genes, syndromes, and therapies. Lancet Neurol 8: 1056-1072.
105. Vandeweyer G, Van der Aa N, Ceulemans B, van Bon BW, Rooms L, Kooy RF. 2012. A de novo balanced t(2;6)(p15;p22.3) in a patient with West syndrome disrupts an lncRNA. Epilepsy Res 99: 346-349.
106. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, et al. 2008. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699.
107. Varley KE, Gertz J, Bowling KM, Parker SL, Reddy TE, Paulibehn F, Cross MK, Williams BA, Stamatoyannopoulos JA, Crawford GE, et al. 2013. Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res 23: 555-567.
108. Wahlestedt C. 2013. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Disc 12: 433-446.
109. Wang T, Pan Q, Lin L, Szulwach KE, Song CX, He C, Wu H, Warren ST, Jin P, Duan R, et al. 2012. Genome-wide DNA hydroxymethylation changes are associated with neuro developmental genes in the developing human cerebellum. Hum Mol Genet 21: 5500-5510.
110. Williams SR, Aldred MA, Der Kaloustian VM, Halal F, Gowans G, McLeod DR, Zondag S, Toriello HV, Magenis RE, Elsea SH. 2010. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am J Hum Genet 87: 219-228.
111. Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, Kaplan DL, Boison D. 2013. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest 123: 3552-3563.
112. Wu J, Xie X. 2006. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol 7: R85.
113. Zhang W, Peterson M, Beyer B, Frankel WN, Zhang ZW. 2014a. Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures. J Neurosci 34: 2754-2763.
114. Zhang Y, Kim J, Mueller AC, Dey B, Yang Y, Lee DH, Hachmann J, Finderle S, Park DM, Christensen J, et al. 2014b. Multiple receptor tyrosine kinases converge on micro-RNA-134 to control KRAS, STAT5B, and glioblastoma. Cell Death Differ 21: 720-734.
115. Zhong J, Chuang SC, Bianchi R, Zhao W, Lee H, Fenton AA, Wong RK, Tiedge H. 2009. BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability. J Neurosci 29: 9977-9986.
116. Zhu Q, Wang L, Zhang Y, Zhao FH, Luo J, Xiao Z, Chen GJ, Wang XF. 2012. Increased expression of DNA methyl transferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci 46: 420-426.
117. Ziller MJ, Muller F, Liao J, Zhang Y, Gu H, Bock C, Boyle P, Epstein CB, Bernstein BE, Lengauer T, et al. 2011. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet 7: e1002389.